Salman Muhammad, Mallhi Tauqeer Hussain, Khan Yusra Habib, Ul Mustafa Zia, Tanweer Abiha, Ikram Muneeba, Hussain Khalid, Butt Muhammad Hammad, Ramdas Nishana, Meyer Johanna C, Godman Brian
Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Lahore, Pakistan.
Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia.
BMJ Open. 2024 Dec 10;14(12):e086877. doi: 10.1136/bmjopen-2024-086877.
This study examined parental experiences with COVID-19 vaccination and factors contributing to COVID-19 vaccine hesitancy (CVH) among them to help guide future policy initiatives.
Cross-sectional study.
Lahore, the second largest metropolis in Pakistan.
This study was conducted among parents residing in Lahore from March to April 2023. Participants were recruited via convenience sampling.
Data were collected using a prevalidated questionnaire that consisted of four sections: (1) informed consent, (2) demographic details, (3) COVID-19 vaccine uptake in children aged 5-17 years, parents' experience with childhood COVID-19 vaccination and their intention to vaccinate their unvaccinated children and (4) a modified 5C scale tailored to determine parents' confidence, complacency, constraints, calculation and collective responsibility with regard to COVID-19 vaccination.
This study included 414 parents (median age=37 years; mothers=62%). COVID-19 vaccination rates for children in the age groups 12-17 years and 5-11 years were 72.5% and 30.1%, respectively. Transient adverse events following immunisation were reported by 32.7% of parents. Of parents with unvaccinated children aged 12-17 years, only 35% intended to vaccinate them. The majority of parents were not willing to vaccinate their children below 11 years of age. Parents with a self-reported positive history of COVID-19 disease (OR=2.531, p=0.016), and confident in the vaccine's safety and efficacy (OR=1.968, p=0.010), were more inclined to vaccinate their 5-11 years. In terms of vaccination of children below 5 years, confidence in the vaccine (OR=2.942, p=0.003) and a sense of collective responsibility were positive predictors (OR=2.260, p=0.035), while calculation was identified as a negative predictor of parents' intention to vaccinate their under 5 years (OR=0.421, p=0.018).
CVH was significantly higher among parents of children aged 5-11 years and children younger than 5 years old. Priority should be given by health authorities to address parental concerns about vaccines and ensure that parents understand the significance of vaccination in protecting their children, to increase vaccination rates. This is because hesitancy towards one specific vaccine can negatively impact hesitancy rates in general.
本研究调查了父母在新冠疫苗接种方面的经历以及导致他们对新冠疫苗犹豫(CVH)的因素,以帮助指导未来的政策举措。
横断面研究。
巴基斯坦第二大城市拉合尔。
本研究于2023年3月至4月在居住在拉合尔的父母中进行。参与者通过便利抽样招募。
使用一份经过预验证的问卷收集数据,该问卷包括四个部分:(1)知情同意,(2)人口统计学细节,(3)5至17岁儿童的新冠疫苗接种情况、父母对儿童新冠疫苗接种的经历以及他们为未接种疫苗的孩子接种疫苗的意愿,(4)一个经过修改的5C量表,用于确定父母在新冠疫苗接种方面的信心、自满、限制、算计和集体责任。
本研究纳入了414名父母(中位年龄 = 37岁;母亲占62%)。12至17岁年龄组和5至11岁年龄组儿童的新冠疫苗接种率分别为72.5%和30.1%。32.7%的父母报告了免疫接种后的短暂不良事件。在12至17岁有未接种疫苗孩子的父母中,只有35%打算为他们接种疫苗。大多数父母不愿意为11岁以下的孩子接种疫苗。有新冠病毒疾病自我报告阳性史的父母(OR = 2.531,p = 0.016),以及对疫苗安全性和有效性有信心的父母(OR = 1.968,p = 0.010),更倾向于为他们5至11岁的孩子接种疫苗。在5岁以下儿童的疫苗接种方面,对疫苗的信心(OR = 2.942,p = 0.003)和集体责任感是积极预测因素(OR = 2.260,p = 0.035),而算计被确定为父母为5岁以下孩子接种疫苗意愿的负向预测因素(OR = 0.421,p = 0.018)。
5至11岁儿童的父母以及5岁以下儿童的父母中,新冠疫苗犹豫现象明显更高。卫生当局应优先解决父母对疫苗的担忧,并确保父母理解接种疫苗对保护孩子的重要性,以提高疫苗接种率。这是因为对一种特定疫苗的犹豫可能会对总体犹豫率产生负面影响。